CYP cynata therapeutics limited

Ann: Publication comparing Cymerus MSCs to other MSCs, page-8

  1. 493 Posts.
    lightbulb Created with Sketch. 148
    And not just GVHD. Cynata and Cymerus is a platform technology.
    OA P3, regardless if it is a TGA or FDA trial will only strengthen CYPs bargaining power.
    Build enough undeniable data while cell therapy landscape and industry appetite increases, then it will be much easier for peers to identify value.
    "ohh a competitor with a Gen 1 tech is $3B and CYP is only $50M.... a $500M TO would be a steal"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
5 277439 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 44900 4
View Market Depth
Last trade - 13.31pm 17/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.